492 related articles for article (PubMed ID: 21450612)
1. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
[TBL] [Abstract][Full Text] [Related]
2. [ADVANCE study: objectives, design and current status].
Chalmers J
Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
[TBL] [Abstract][Full Text] [Related]
3. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
Du X; Ninomiya T; de Galan B; Abadir E; Chalmers J; Pillai A; Woodward M; Cooper M; Harrap S; Hamet P; Poulter N; Lip GY; Patel A;
Eur Heart J; 2009 May; 30(9):1128-35. PubMed ID: 19282274
[TBL] [Abstract][Full Text] [Related]
4. Implications of the ADVANCE study for clinical practice.
Zannad F
J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
[TBL] [Abstract][Full Text] [Related]
5. Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation.
van der Leeuw J; Visseren FL; Woodward M; Zoungas S; Kengne AP; van der Graaf Y; Glasziou P; Hamet P; MacMahon S; Poulter N; Grobbee DE; Chalmers J
Hypertension; 2015 Jan; 65(1):115-21. PubMed ID: 25312436
[TBL] [Abstract][Full Text] [Related]
6. A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR).
Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Gudbjörnsdottir S;
Diabet Med; 2011 Oct; 28(10):1213-20. PubMed ID: 21627687
[TBL] [Abstract][Full Text] [Related]
7. Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].
Ghiadoni L
Expert Opin Pharmacother; 2010 Jul; 11(10):1647-57. PubMed ID: 20518617
[TBL] [Abstract][Full Text] [Related]
8. Prediction of kidney-related outcomes in patients with type 2 diabetes.
Jardine MJ; Hata J; Woodward M; Perkovic V; Ninomiya T; Arima H; Zoungas S; Cass A; Patel A; Marre M; Mancia G; Mogensen CE; Poulter N; Chalmers J;
Am J Kidney Dis; 2012 Nov; 60(5):770-8. PubMed ID: 22694950
[TBL] [Abstract][Full Text] [Related]
9. [ADVANCE: a morbidity mortality study of diabetes and hypertension].
Heim A; Feihl F; Waeber B
Rev Med Suisse; 2008 Jan; 4(139):28, 30, 32-3. PubMed ID: 18251212
[TBL] [Abstract][Full Text] [Related]
10. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study.
Kengne AP; Patel A; Colagiuri S; Heller S; Hamet P; Marre M; Pan CY; Zoungas S; Grobbee DE; Neal B; Chalmers J; Woodward M;
Diabetologia; 2010 May; 53(5):821-31. PubMed ID: 20157695
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.
Ninomiya T; Zoungas S; Neal B; Woodward M; Patel A; Perkovic V; Cass A; Cooper M; Grobbee D; Hamet P; Harrap S; Liu L; Mancia G; Mogensen CE; Poulter N; Rodgers A; Williams B; MacMahon S; Chalmers J;
J Hypertens; 2010 Jun; 28(6):1141-9. PubMed ID: 20486273
[TBL] [Abstract][Full Text] [Related]
14. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
Waeber B; de la Sierra A; Ruilope LM
Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
[TBL] [Abstract][Full Text] [Related]
15. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
16. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
17. ADVANCE: action in diabetes and vascular disease.
Patel A; Chalmers J; Poulter N
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S27-32. PubMed ID: 16075030
[TBL] [Abstract][Full Text] [Related]
18. Multiple biomarkers for the prediction of first major cardiovascular events and death.
Wang TJ; Gona P; Larson MG; Tofler GH; Levy D; Newton-Cheh C; Jacques PF; Rifai N; Selhub J; Robins SJ; Benjamin EJ; D'Agostino RB; Vasan RS
N Engl J Med; 2006 Dec; 355(25):2631-9. PubMed ID: 17182988
[TBL] [Abstract][Full Text] [Related]
19. Advances in reducing the burden of vascular disease in type 2 diabetes.
Chalmers J; Joshi R; Patel A
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):434-7. PubMed ID: 18307736
[TBL] [Abstract][Full Text] [Related]
20. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
Nilsson PM
Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
[No Abstract] [Full Text] [Related]
[Next] [New Search]